CN104824662A - Lactic acid bacteria composition capable of regulating intestinal flora functions and preparation method and application thereof - Google Patents
Lactic acid bacteria composition capable of regulating intestinal flora functions and preparation method and application thereof Download PDFInfo
- Publication number
- CN104824662A CN104824662A CN201510170841.1A CN201510170841A CN104824662A CN 104824662 A CN104824662 A CN 104824662A CN 201510170841 A CN201510170841 A CN 201510170841A CN 104824662 A CN104824662 A CN 104824662A
- Authority
- CN
- China
- Prior art keywords
- parts
- regulating intestinal
- bacteria composition
- intestinal canal
- lactic bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 46
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract description 18
- 239000004310 lactic acid Substances 0.000 title abstract description 9
- 235000014655 lactic acid Nutrition 0.000 title abstract description 9
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 29
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 29
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 29
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 26
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 26
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 25
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims description 13
- 235000013402 health food Nutrition 0.000 claims description 12
- 239000005913 Maltodextrin Substances 0.000 claims description 10
- 229920002774 Maltodextrin Polymers 0.000 claims description 10
- 239000000845 maltitol Substances 0.000 claims description 10
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 10
- 229940035436 maltitol Drugs 0.000 claims description 10
- 235000010449 maltitol Nutrition 0.000 claims description 10
- 229940035034 maltodextrin Drugs 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 abstract 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract 1
- 229940107187 fructooligosaccharide Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000686 essence Substances 0.000 description 9
- 241000186660 Lactobacillus Species 0.000 description 8
- 229940039696 lactobacillus Drugs 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 210000000936 intestine Anatomy 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 5
- 229940009289 bifidobacterium lactis Drugs 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000606125 Bacteroides Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000305071 Enterobacterales Species 0.000 description 3
- 241000194033 Enterococcus Species 0.000 description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 3
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000304886 Bacilli Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012009 microbiological test Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229940022663 acetate Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Abstract
The invention discloses a lactic acid bacteria composition capable of regulating intestinal flora functions and preparation method and application thereof. The active ingredients of the lactic acid bacteria composition capable of regulating intestinal flora functions are prepared from the following raw materials by weight: 20-40 parts of Lactobacillus acidophilus, 40-60 parts of Bifidobacterium longum, 20-60 parts of Lactobacillus rhamnosus, 30-60 parts of Streptococcus thermophilus and 35-75 parts of fructo-oligosaccharide. According to the lactic acid bacteria composition capable of regulating intestinal flora functions, lactic acid bacteria in the composition can reach a certain magnitude, and the raw materials are in reasonable compatibility, and have a good function of regulating intestinal flora. The lactic acid bacteria composition has good stability in a long time, and is suitable for the diabetics to eat.
Description
Technical field
The present invention relates to field of health care food, particularly relate to lactic bacteria composition of a kind of tool regulating intestinal canal flora function and preparation method thereof and application.
Background technology
Colony balance and intestinal health closely bound up.Gut flora comprises beneficial bacterium and harmful bacteria.In healthy human body, beneficial bacterium is preponderated, and interacts with harmful bacteria, jointly maintains the balance of Tiny ecosystem in intestines, maintains health.If make the probio in enteron aisle reduce because of various factors impact, harmful bacteria amount reproduction, in intestines, microecological balance is broken, and will cause the various clinical symptoms such as diarrhoea.Usually can use broad-spectrum antibiotic in a large number clinically, although can effective kill harmful bacterium, also can kill beneficial bacterium simultaneously, cause intestinal bacilli illness, cause disease.
For intestinal bacilli illness person, per os probiotic supplemented preparation is the way of directly effectively regulating intestinal canal flora.It directly or indirectly can adjust the composition of host intestine microorganism, and activation host endogenous microbes group or immune activity realize prebiotic effect.
Although probiotic food has many benefits to health, but manufacturer asks to adapt to the taste that consumer is afraid of acid, and manufactured goods all with the addition of a large amount of sugars, and fruity Yoghourt carrys out seasoning with flavoring essence.In addition, also there is shelf-life short, the shortcoming such as storage cost of transportation is high in the liquid form product such as lactobacillus yogurt.And, kinds of lactobacillus is various, preferably suitable bacterial classification also carries out reasonably combined to reach the difficult point that better health-care effect is also this area now, therefore develop that a kind of strain collocation is reasonable, nutrition good, sugar content is low, long shelf-life, steady quality, and the lactic bacteria composition with good health-care effect is necessary.
Summary of the invention
Based on this, be necessary for the problems referred to above, provide lactic bacteria composition of a kind of tool regulating intestinal canal flora function and preparation method thereof and application, lactic bacteria composition strain collocation of the present invention is reasonable, nutrition good, sugar content is low, long shelf-life, steady quality, and there is good health-care effect.
For realizing above-mentioned technical purpose, concrete technical scheme is as follows:
A lactic bacteria composition for tool regulating intestinal canal flora function, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 20 ~ 40 parts, bifidobacterium longum 40 ~ 60 parts, Lactobacillus rhamnosus 20 ~ 60 parts, streptococcus thermophilus 30 ~ 60 parts, FOS 35 ~ 75 parts.
Inventor team is according to technical purpose of the present invention, in conjunction with the functional characteristic such as the security of all types of probio, field planting and adhesive force, antibacterial, acidproof and bile tolerance ability, by a large amount of research and experiments, probio is screened, finally preferred Lactobacillus rhamnosus, bifidobacterium longum, lactobacillus acidophilus, streptococcus thermophilus.Lactobacillus and Bifidobacterium are the important physiology bacterium of human intestine, to the physiological action that body has other normal physiological bacterium multiple incomparable, comprising: regulating intestinal canal flora, strengthen host intestine resistance, prevention and therapy diarrhoea etc.Lactobacillus acidophilus and Lactobacillus rhamnosus belong to lactobacillus, and the former is present in the small intestine site of very strictly anaerobic environment, have stronger acidproof and resistance to bile ability, can are colonizated in large intestine smoothly by gastrointestinal environment; And Lactobacillus rhamnosus can grow very well under anaerobic conditions, enteron aisle Stickiness is higher, and colonization ability is strong, and the ability of its resistance to intestinal environment is better than common sour milk bacterial classification and other probio bacterial classification, plays the effect such as regulating intestinal canal flora, prevention and therapy diarrhoea; Streptococcus thermophilus, as potential beneficial bacterium, can arrive the first half of small intestine, has certain intestines and stomach adhesiveness and transport activity; Bifidobacterium longum is present in large intestines, can adhere to host's intestinal epithelial cell surface, form stable flora, play biological barrier and Ant agonism.Bifidobacterium longum repels pathogenic bacteria by self and the metabolite that produces, and in enteron aisle, keep flora advantage, and interact with other flora, the relation between adjustment flora, and maintains colony balance.
There is intergrowth relation in lactobacillus acidophilus preferred for this invention, Lactobacillus rhamnosus, streptococcus thermophilus, bifidobacterium longum, need acetate, vitamin B2 and folic acid etc. as nutriment in the growth of lactobacillus acidophilus, and bifidobacterium longum in fermentation except generating penta acetic acid, can also the multivitamin such as synthetic vitamin B1, B2, B12 and folic acid, just supply the needs of lactobacillus acidophilus, promote the growing multiplication of lactobacillus acidophilus.Lactobacillus acidophilus grows soon in micro-oxygen containing newborn matrix, progressively can reduce the oxidation-reduction potential in newborn matrix, and provide the material of various decomposed easy utilization, promotes the growth of bifidobacterium longum; Lactobacillus rhamnosus homofermentation, produce Pfansteihl, can ferment multiple sugar, promotes the growth of the beneficial bacterium such as bifidobacterium longum and lactobacillus; When lactobacillus acidophilus and streptococcus thermophilus mixed culture fermentation, compensate for streptococcus thermophilus because of the more weak and defect in the nutrition caused of the ability of decomposing protein, accelerate the growth of streptococcus thermophilus; Lactic acid, formic acid etc. that simultaneously streptococcus thermophilus metabolism produces are the growth stimulants of lactobacillus acidophilus, can play facilitation in various degree to lactobacillus acidophilus.FOS is as the prebiotics of a kind of Be very effective, high-quality, lactobacillus acidophilus can be made at lower doses, bifidobacterium longum is multiplied, much lower compared with its utility scale of other compound sugar, but effect is more obvious, and FOS water activity is lower compared with other prebioticses, can better be composite with probio, ensure that probio keeps active within the longer shelf-life.The compatibility of lactobacillus acidophilus, Lactobacillus rhamnosus, streptococcus thermophilus, bifidobacterium longum and FOS is rational, formula is while probiotic supplemented and prebiotics, increase intestines peristalsis, bacterium excessively increases in control, regulating intestinal canal flora and the normal pH value of recovery enteron aisle.
Wherein in some embodiments, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 25 ~ 35 parts, bifidobacterium longum 45 ~ 55 parts, Lactobacillus rhamnosus 35 ~ 45 parts, streptococcus thermophilus 35 ~ 45 parts, FOS 45 ~ 65 parts.
Wherein in some embodiments, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 29 ~ 31 parts, bifidobacterium longum 49 ~ 51 parts, Lactobacillus rhamnosus 39 ~ 41 parts, streptococcus thermophilus 39 ~ 41 parts, FOS 54 ~ 56 parts.
The present invention also provides a kind of preparation method of lactic bacteria composition of above-mentioned tool regulating intestinal canal flora function, comprises the steps:
1) take raw material according to above-mentioned proportioning, described raw material is lactobacillus acidophilus, bifidobacterium longum, Lactobacillus rhamnosus, streptococcus thermophilus, FOS;
2) by step 1) gained raw material mixes with auxiliary material acceptable on health food, sieves, mix.
Wherein in some embodiments, on described health food, acceptable auxiliary material is maltitol 35 ~ 65 parts, maltodextrin 30 ~ 70 parts, flavoring essence 5 ~ 15 parts.
Wherein in some embodiments, on described health food, acceptable auxiliary material is maltitol 51 ~ 53 parts, maltodextrin 49 ~ 51 parts, flavoring essence 9 ~ 11 parts.
The lactic bacteria composition that present invention also offers above-mentioned tool regulating intestinal canal flora function is preparing the application in health food.
Present invention also offers a kind of health food, described health food includes the lactic bacteria composition of above-mentioned tool regulating intestinal canal flora function.
The present invention compared to the advantage of prior art and beneficial effect is:
(1) the present invention through inventor team for a long time for the research of lactic acid bacteria, and a large amount of experiments and contrast test, preferably comprise lactobacillus acidophilus, bifidobacterium longum, Lactobacillus rhamnosus, the raw material components of streptococcus thermophilus and FOS, and preferred optimum proportioning, above-mentioned raw materials component cooperatively interacts, have and regulate body composition of gut flora, keep microecological balance, recover the functions such as the normal pH value of enteron aisle, the present invention can make lactic acid bacteria in lactic bacteria composition reach some levels, each material combination is reasonable, there is good regulating intestinal canal flora function, gained lactic bacteria composition good stability in a long time, and be applicable to diabetes patient.
(2) preparation method of the present invention is easy and simple to handle, reliable, productivity effect is high, is applicable to the large production of industry.
Detailed description of the invention
Raw materials usedly in embodiment be commercially available convenient source.
Use in following examples and comparative example lactobacillus acidophilus, bifidobacterium longum, Lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus bulgaricus, bifidobacterium lactis is all purchased from Jin Qiao bio tech ltd, Anhui.
Below in conjunction with specific embodiment, set forth the present invention further.
Embodiment 1
A lactic bacteria composition for tool regulating intestinal canal flora function, it is prepared from by following raw material:
Lactobacillus acidophilus 20 parts, bifidobacterium longum 60 parts, Lactobacillus rhamnosus 60 parts, streptococcus thermophilus 30 parts, FOS 75 parts, flavoring essence 15 parts, maltitol 35 parts, maltodextrin 70 parts.
The preparation method of the lactic bacteria composition of above-mentioned tool regulating intestinal canal flora function comprises the steps:
1) lactobacillus acidophilus, bifidobacterium longum, Lactobacillus rhamnosus, streptococcus thermophilus, FOS is taken according to said ratio;
2) by step 1) each raw material mix with flavoring essence, maltitol, maltodextrin, cross 50 mesh sieves, be placed in total mixed machine, mix;
3) by step 2) products obtained therefrom is checked, packing: inspect by random samples by control standard in enterprise product, after the assay was approved, and packing, packing specification: 5g/ wraps;
4) extract point product installed on request, test by target level of product quality;
5) after the assay was approved, after quality department provides verification of conformity, outsourcing, warehouse-in.
Embodiment 2
A lactic bacteria composition for tool regulating intestinal canal flora function, it is prepared from by following raw material:
Lactobacillus acidophilus 40 parts, bifidobacterium longum 40 parts, Lactobacillus rhamnosus 20 parts, streptococcus thermophilus 60 parts, FOS 35 parts, flavoring essence 5 parts, maltitol 65 parts, maltodextrin 30 parts.
Embodiment 2 preparation method and embodiment 1 are together.
Embodiment 3
A lactic bacteria composition for tool regulating intestinal canal flora function, it is prepared from by following raw material:
Lactobacillus acidophilus 30 parts, bifidobacterium longum 50 parts, Lactobacillus rhamnosus 40 parts, streptococcus thermophilus 40 parts, FOS 55 parts, flavoring essence 10 parts, maltitol 52 parts, maltodextrin 50 parts.
Embodiment 3 preparation method and embodiment 1 are together.
Embodiment 4
It is below the quality standard for lactic bacteria composition that inventor and team thereof formulate according to food security GB etc.
Table 1 lactic bacteria composition quality standard Q/SYSW0003S-2011
Embodiment 5
The microorganism of the lactic bacteria composition of the tool regulating intestinal canal flora function obtained by embodiment 3 and sanitary index detect
Detect every microorganism of the lactic bacteria composition of the embodiment of the present invention 3 tool regulating intestinal canal flora function according to " GB 7101-2003 solid beverage sanitary standard " and " lactic bacteria composition quality standard Q/SYSW0003S-2011 " and chemical index as follows:
The lactic bacteria composition microorganism of table 2 embodiment 3 tool regulating intestinal canal flora function and sanitary index
Embodiment 6
The lactic bacteria composition stability test result of the tool regulating intestinal canal flora function obtained by embodiment 3
Stability sense organ: sample (obtains the lactic bacteria composition of the tool regulating intestinal canal flora function of three batches again according to embodiment 3 technical scheme, be respectively 513120803,513120804,513120805) be white powder, there is the distinctive smell of this product, free from extraneous odour, without naked eyes visible foreign; Sample deposits 18 months under nature (normal temperature) condition, and the organoleptic indicators such as the color of product, proterties, smell and quality are all normal, without significant change occurs.Micro biological Tests result and physical and chemical inspection result are specifically in table 3 and table 4.
The lactic bacteria composition stability experiment testing result (depositing 0 month) of table 3 embodiment of the present invention 3 tool regulating intestinal canal flora function
Check-Out Time is: on August 12 ,-2012 years on the 5th August in 2012
The lactic bacteria composition stability experiment testing result (after depositing 18 months) of table 4 embodiment of the present invention 3 tool regulating intestinal canal flora function
Check-Out Time is: on February 12 ,-2014 years on the 5th February in 2014
According to examination by sensory organs result, Micro biological Tests result, the physical and chemical inspection result of the said goods stability test, the lactic bacteria composition that the present invention has regulating intestinal canal flora function deposits 18 months under nature (normal temperature) condition, the inherent quality index of product and sanitary index meet product relevant criterion, point out this constant product quality.
Embodiment 7
The lactic bacteria composition acute toxicity test of the tool regulating intestinal canal flora function obtained by embodiment 3
Test method: select body weight 18-22g healthy NIH kind small white mouse 20, male and female half and half.Adopt maximum tolerance measurement Law, if tested material preparation is 20.0g/kg.BW, take sample (lactic bacteria composition of the tool regulating intestinal canal flora function obtained by embodiment 3) during test, every 20.0g pure water is diluted to 30ml for examination.Fasting can't help water after 16 hours, and once, gavage amount is 0.3ml/10g.BW to gavage, observes one week, record mouse poisoning manifestations and death condition.
Result of the test and discussion: observe per os gavage after one week, do not observe animal and occur bad reaction, according to acute toxicity classification, the lactic bacteria composition of tested material tool of the present invention regulating intestinal canal flora function belongs to nontoxic level material.
Embodiment 8 human experimentation method
8.1 experimenter's mass selections are selected in nearly one month and were not suffered from gastrointestinal disease, do not take antibiotic, age 20-65 year, health check-up index is normal volunteer 90 all.
Volunteer is divided into experimental group and control group 1, control group 2 with grouping by 8.2 dosage at random, and often organize 30 people, men and women half and half.
8.3 experimental technique experimental group take the lactic bacteria composition of tool regulating intestinal canal flora function obtained by embodiment 3; Control group 1, control group 2 take comparative example 1, comparative example 2 (concrete formula asks for an interview following comparative example 1,2) preparation respectively.Test group and control group instructions of taking are every day 1 time, each 1 bag, take 15 days continuously.Be responsible for sending out sample by special messenger and supervised and take, duration of test does not change original eating habit, normal diet.Test group and each control group are before taking tested material and take tested material continuously after 15 days, aseptic collection ight soil carries out 10 times of serial dilutions respectively, select suitable dilution factor, be seeded on various culture medium respectively, cultivate on request, then bacterium colony (enterobacteriaceae lactobacteriaceae (enterobacteria), enterococcus, Bifidobacterium, lactobacillus, bacteroid and aerogenesis folder film bacillus) counting is carried out to culture.
Comparative example 1,2 is filled a prescription as follows:
Comparative example 1
A kind of lactic bacteria composition, its preparation method is substantially the same manner as Example 3, and difference is also to contain bifidobacterium lactis, lactobacillus bulgaricus in its formula, not containing Lactobacillus rhamnosus, is specially:
Lactobacillus acidophilus 35 parts, bifidobacterium longum 55 parts, lactobacillus bulgaricus 35 parts, streptococcus thermophilus 30 parts, bifidobacterium lactis 35 parts, FOS 55 parts, flavoring essence 10 parts, maltitol 52 parts, maltodextrin 50 parts.
Comparative example 2
A kind of lactic bacteria composition, its preparation method is substantially the same manner as Example 3, and difference is also to contain bifidobacterium lactis in its formula, not containing Lactobacillus rhamnosus, streptococcus thermophilus, is specially:
Lactobacillus acidophilus 40 parts, bifidobacterium longum 55 parts, bifidobacterium lactis 45 parts, FOS 55 parts, flavoring essence 10 parts, maltitol 52 parts, maltodextrin 50 parts.
8.4 experimental results and analytical table
Table 5 human experiment group foretastes front and back flora situation and compares (cfu/g)
As shown in Table 5, compared with control group 1, control group 2, experimental group crowd is after the lactic bacteria composition of the tool regulating intestinal canal flora function obtained by edible embodiment 3, the quantity of Bifidobacterium and lactobacillus significantly increases, and enterobacteria, enterococcus, bacteroid and C.perfringens quantity all decrease.
Human test results: from table 5, after the lactic bacteria composition of edible tool regulating intestinal canal flora function obtained by embodiment 3, experimental group lactobacillus and Bifidobacterium are accelerated and are significantly higher than control group, and enterobacteria, enterococcus, bacteroid and C.perfringens all decrease before edible.
Above-mentioned human trial shows: the lactic bacteria composition of tool regulating intestinal canal flora function of the present invention has the effect of regulating intestinal canal colony balance.
Each technical characteristic of the above embodiment can combine arbitrarily, for making description succinct, the all possible combination of each technical characteristic in above-described embodiment is not all described, but, as long as the combination of these technical characteristics does not exist contradiction, be all considered to be the scope that this description is recorded.
The above embodiment only have expressed several embodiment of the present invention, and it describes comparatively concrete and detailed, but can not therefore be construed as limiting the scope of the patent.It should be pointed out that for the person of ordinary skill of the art, without departing from the inventive concept of the premise, can also make some distortion and improvement, these all belong to protection scope of the present invention.Therefore, the protection domain of patent of the present invention should be as the criterion with claims.
Claims (8)
1. the lactic bacteria composition of a tool regulating intestinal canal flora function, it is characterized in that, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 20 ~ 40 parts, bifidobacterium longum 40 ~ 60 parts, Lactobacillus rhamnosus 20 ~ 60 parts, streptococcus thermophilus 30 ~ 60 parts, FOS 35 ~ 75 parts.
2. the lactic bacteria composition of tool regulating intestinal canal flora function according to claim 1, it is characterized in that, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 25 ~ 35 parts, bifidobacterium longum 45 ~ 55 parts, Lactobacillus rhamnosus 35 ~ 45 parts, streptococcus thermophilus 35 ~ 45 parts, FOS 45 ~ 65 parts.
3. the lactic bacteria composition of tool regulating intestinal canal flora function according to claim 2, it is characterized in that, its active component is prepared from by the raw material of following weight portion: lactobacillus acidophilus 29 ~ 31 parts, bifidobacterium longum 49 ~ 51 parts, Lactobacillus rhamnosus 39 ~ 41 parts, streptococcus thermophilus 39 ~ 41 parts, FOS 54 ~ 56 parts.
4. a preparation method for the lactic bacteria composition of the tool regulating intestinal canal flora function described in any one of claims 1 to 3, is characterized in that, comprise the steps:
1) take raw material according to the proportioning described in any one of claims 1 to 3, described raw material is lactobacillus acidophilus, bifidobacterium longum, Lactobacillus rhamnosus, streptococcus thermophilus, FOS;
2) by step 1) gained raw material mixes with auxiliary material acceptable on health food, sieves, mix.
5. preparation method according to claim 4, is characterized in that, on described health food, acceptable auxiliary material is maltitol 35 ~ 65 parts, maltodextrin 30 ~ 70 parts, flavoring essence 5 ~ 15 parts.
6. preparation method according to claim 5, is characterized in that, on described health food, acceptable auxiliary material is maltitol 51 ~ 53 parts, maltodextrin 49 ~ 51 parts, flavoring essence 9 ~ 11 parts.
7. the lactic bacteria composition of the tool regulating intestinal canal flora function as described in any one of claims 1 to 3 is preparing the application in health food.
8. a health food, is characterized in that, described health food includes the lactic bacteria composition of the tool regulating intestinal canal flora function as described in any one of claims 1 to 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510170841.1A CN104824662B (en) | 2015-04-10 | 2015-04-10 | Lactic bacteria composition of tool regulation gut flora function and preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510170841.1A CN104824662B (en) | 2015-04-10 | 2015-04-10 | Lactic bacteria composition of tool regulation gut flora function and preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104824662A true CN104824662A (en) | 2015-08-12 |
| CN104824662B CN104824662B (en) | 2017-10-13 |
Family
ID=53803183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510170841.1A Active CN104824662B (en) | 2015-04-10 | 2015-04-10 | Lactic bacteria composition of tool regulation gut flora function and preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104824662B (en) |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920049A (en) * | 2016-06-02 | 2016-09-07 | 扬州大学 | Application of lactobacillus rhamnosus grx19 in regulation of intestinal floras |
| CN106417989A (en) * | 2016-02-02 | 2017-02-22 | 武汉万德瑞生物技术有限公司 | Probiotic composition for aquatic animal feed, preparation method and application thereof |
| CN106509913A (en) * | 2016-10-25 | 2017-03-22 | 天益健康科学研究院（镇江）有限公司 | Composition for regulating balance of intestinal flora |
| CN106619742A (en) * | 2016-11-08 | 2017-05-10 | 江西益盟科技有限公司 | Lactic acid bacteria composition used for treating diabetes, and preparation method thereof |
| CN106668078A (en) * | 2016-12-14 | 2017-05-17 | 天津迎南科技有限公司 | Novel material composition for activity regulation of intestinal flora and preparation method of novel material composition |
| CN107455757A (en) * | 2017-07-21 | 2017-12-12 | 杜亚东 | A kind of probiotic composition for adjusting enteron aisle |
| CN108142928A (en) * | 2017-12-25 | 2018-06-12 | 北京数果科技有限公司 | For the compound probiotic composition of intestinal canal regulating and its application |
| CN109123679A (en) * | 2018-08-21 | 2019-01-04 | 卓源健康科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN109123680A (en) * | 2018-09-10 | 2019-01-04 | 富益元（东莞）生物科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN109805413A (en) * | 2019-03-14 | 2019-05-28 | 广州普维君健药业有限公司 | Mend folic acid composition and its preparation method and application |
| CN110464741A (en) * | 2019-02-25 | 2019-11-19 | 山东中微众康生物科技有限公司 | A kind of lactic acid bacteria oral liquor and preparation method thereof improving human body intestinal canal health |
| CN110604240A (en) * | 2018-06-14 | 2019-12-24 | 江苏昊特食品科技有限公司 | Lactic acid bacteria and method for preparing beverage by using same |
| CN111053244A (en) * | 2019-12-06 | 2020-04-24 | 山东体育学院 | Nutrition regulation method and system based on intestinal microorganisms |
| CN111084386A (en) * | 2020-02-28 | 2020-05-01 | 大连万众益生大健康有限公司 | Probiotic supplement with function of improving intestinal tract |
| CN111955741A (en) * | 2020-08-12 | 2020-11-20 | 量子高科(中国)生物股份有限公司 | Composition for weight control and application thereof |
| CN114344341A (en) * | 2022-01-21 | 2022-04-15 | 广州市沐家健康产业有限公司 | Composite probiotic composition with intestinal tract regulating effect and preparation method and application thereof |
| CN114947134A (en) * | 2022-05-06 | 2022-08-30 | 河北一然生物科技股份有限公司 | Application of streptococcus thermophilus S131 in improving intestinal health and regulating intestinal flora |
-
2015
- 2015-04-10 CN CN201510170841.1A patent/CN104824662B/en active Active
Non-Patent Citations (1)
| Title |
|---|
| 张勇 等: "世界益生菌产品研究和发展趋势", 《中国微生态学杂志》 * |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106417989A (en) * | 2016-02-02 | 2017-02-22 | 武汉万德瑞生物技术有限公司 | Probiotic composition for aquatic animal feed, preparation method and application thereof |
| CN105920049A (en) * | 2016-06-02 | 2016-09-07 | 扬州大学 | Application of lactobacillus rhamnosus grx19 in regulation of intestinal floras |
| CN106509913A (en) * | 2016-10-25 | 2017-03-22 | 天益健康科学研究院（镇江）有限公司 | Composition for regulating balance of intestinal flora |
| CN106619742A (en) * | 2016-11-08 | 2017-05-10 | 江西益盟科技有限公司 | Lactic acid bacteria composition used for treating diabetes, and preparation method thereof |
| CN106668078A (en) * | 2016-12-14 | 2017-05-17 | 天津迎南科技有限公司 | Novel material composition for activity regulation of intestinal flora and preparation method of novel material composition |
| CN107455757A (en) * | 2017-07-21 | 2017-12-12 | 杜亚东 | A kind of probiotic composition for adjusting enteron aisle |
| CN108142928A (en) * | 2017-12-25 | 2018-06-12 | 北京数果科技有限公司 | For the compound probiotic composition of intestinal canal regulating and its application |
| CN110604240A (en) * | 2018-06-14 | 2019-12-24 | 江苏昊特食品科技有限公司 | Lactic acid bacteria and method for preparing beverage by using same |
| CN109123679A (en) * | 2018-08-21 | 2019-01-04 | 卓源健康科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN109123680A (en) * | 2018-09-10 | 2019-01-04 | 富益元（东莞）生物科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN110464741A (en) * | 2019-02-25 | 2019-11-19 | 山东中微众康生物科技有限公司 | A kind of lactic acid bacteria oral liquor and preparation method thereof improving human body intestinal canal health |
| CN109805413A (en) * | 2019-03-14 | 2019-05-28 | 广州普维君健药业有限公司 | Mend folic acid composition and its preparation method and application |
| CN111053244A (en) * | 2019-12-06 | 2020-04-24 | 山东体育学院 | Nutrition regulation method and system based on intestinal microorganisms |
| CN111084386A (en) * | 2020-02-28 | 2020-05-01 | 大连万众益生大健康有限公司 | Probiotic supplement with function of improving intestinal tract |
| CN111955741A (en) * | 2020-08-12 | 2020-11-20 | 量子高科(中国)生物股份有限公司 | Composition for weight control and application thereof |
| CN111955741B (en) * | 2020-08-12 | 2022-11-11 | 量子高科(广东)生物有限公司 | Composition for weight control and application thereof |
| CN114344341A (en) * | 2022-01-21 | 2022-04-15 | 广州市沐家健康产业有限公司 | Composite probiotic composition with intestinal tract regulating effect and preparation method and application thereof |
| CN114947134A (en) * | 2022-05-06 | 2022-08-30 | 河北一然生物科技股份有限公司 | Application of streptococcus thermophilus S131 in improving intestinal health and regulating intestinal flora |
| CN114947134B (en) * | 2022-05-06 | 2024-01-26 | 河北一然生物科技股份有限公司 | Application of streptococcus thermophilus S131 in improving intestinal health and regulating intestinal flora |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104824662B (en) | 2017-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104824662B (en) | Lactic bacteria composition of tool regulation gut flora function and preparation method and application | |
| Mohan et al. | Effect of honey in improving the gut microbial balance | |
| Douglas et al. | Probiotics and prebiotics in dietetics practice | |
| Vieira et al. | The impact of fruit and soybean by-products and amaranth on the growth of probiotic and starter microorganisms | |
| Sanz et al. | Understanding the role of gut microbes and probiotics in obesity: how far are we? | |
| Rolim | Development of prebiotic food products and health benefits | |
| Voreades et al. | Diet and the development of the human intestinal microbiome | |
| Woodmansey | Intestinal bacteria and ageing | |
| CN101449830B (en) | Mid-aged milk powder added with biostime and preparation method thereof | |
| Hasani et al. | Physicochemical and sensory attributes assessment of functional low‐fat yogurt produced by incorporation of barley bran and Lactobacillus acidophilus | |
| TR201815566T4 (en) | Treatment of obesity, metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease using at least one bacterial strain from Prevotella. | |
| dos Santos Leandro et al. | Survival of Lactobacillus delbrueckii UFV H2b20 in ice cream produced with different fat levels and after submission to stress acid and bile salts | |
| CN107019701A (en) | The method that the incidence of disease of the necrotizing enterocolitis of baby, child or children is reduced using human milk oligosaccharides | |
| CN104397818A (en) | Multifunctional compound health care solid beverage and preparation method thereof | |
| CN101945658A (en) | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants | |
| Rahayu et al. | Gut microbiota profile in healthy Indonesians | |
| CN106860483A (en) | Probiotics complex composition and application containing Bifidobacterium and lactobacillus acidophilus | |
| Zamora-Vega et al. | Effect of incorporating prebiotics in coating materials for the microencapsulation of Sacharomyces boulardii | |
| MacDonald et al. | Specific prebiotics in a formula for infants with Phenylketonuria | |
| Tesfaye et al. | Dairy and nondairy-based beverages as a vehicle for probiotics, prebiotics, and symbiotics: Alternatives to health versus disease binomial approach through food | |
| Dronkers et al. | The ascent of the blessed: Regulatory issues on health effects and health claims for probiotics in Europe and the rest of the world | |
| Mehrinejad Choobari et al. | Effect of Plantago ovata Forsk seed mucilage on survivability of Lactobacillus acidophilus, physicochemical and sensory attributes of produced low‐fat set yoghurt | |
| Mishra et al. | Current trends in non-dairy based synbiotics | |
| Paturi et al. | Goat and cow milk powder-based diets with or without prebiotics influence gut microbial populations and fermentation products in newly weaned rats | |
| CN109715784A (en) | Bacterium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |